1. Market Research
  2. > Biotechnology
  3. > Genetically Modified Organism Market Trends
Competent Cells Market by Type, Application, End User - Global Forecast to 2022

Competent Cells Market: Global Forecast until 2022

  • July 2017
  • 162 pages
  • ID: 5018010
In this report:
In 2017, North America is expected to account for the largest share of ##.##% of this market and grow at the highest CAGR of ##.##% during the forecast period.
The pharmaceutical and biotechnology companies segment is expected to hold the second-largest market share during the forecast period; however, it will also grow at the highest rate of ##.##% between 2017 and 2022.


Table of Contents

Search Inside

The overall competent cells market is estimated to grow ~$2.2B by 2022 from ~$1.4B in 2017, at a compound annual growth rate (CAGR) of 10.20 percent

Advancements in molecular cloning research due to the emergence of new technologies and the increasing commercial demand for molecular cloned products and recombinant proteins are some the top factors driving the rise of this market. On the other hand, growing market consolidation creating strong entry barriers and high cost of competent cells kits are selecting the increase of this market.

The electrocompetent cells segment is expected to record the maximal CAGR (Compound annual growth rate) during the outlook period

The competent cells market is classified on the basis of class into chemically competent cells and electrocompetent cells. Electrocompetent cells are anticipated to grow at the maximal compound annual growth rate (CAGR) during the estimate period. Electrocompetent cells offer high transformation efficiencies, making them suitable for many molecular biology applications including the generation of cDNA libraries or constructing gene banks.

Increasing intensity of research and technological improvements drives increase of the other applications segment

Established on application, the overall competent cells market is mostly broken down into cloning, protein expression, and other applications. The other applications segment is projected to register the highest CAGR (Compound annual growth rate) during the outlook period. This industry segment comprises of mutagenesis, single-stranded DNA production, lentiviral vector production, and big plasmid transformation. The increase in this industry segment is primarily attributed to rising intensity of research and technological improvements.

Pharmaceutical & biotechnology companies segment is anticipated to witness the highest increase

The competent cells market is classified on the basis of end users into academic research institutes, contract research organizations, and pharmaceutical & biotechnology firms. Pharmaceutical & biotechnology firms are anticipated to grow at the highest compound annual growth rate (CAGR) during the estimate period. This is primarily due to the growing investments in industry research for developing genomics and proteomics-based products.

North America continent to account for the biggest share of the market

Geographically, the competent cells market is leaded by, is monopolized by North America (NA), succeeded by EU. The North American area is expected to account for the biggest share in 2017, and the trend is anticipated to continue during the outlook period. The rise in this sector can be accredited to the presence of main main actors in the territory, technological improvements, increase in the biotechnology and pharmaceutical sectors, and growing inclination towards analysis established on genomics and proteomics.

The primary interviews conducted for this market report can be categorized as follows:

• By Company category - Tier 1 - 25 %, Tier 2 - 35.0 percent and Tier 3 - 40.0 percent

• By Description - C-suite - 35.0 percent, Director-level - 25.0 percent, Others - 40.0 percent

• By Area - North America continent - 43.0 percent, Europe (EU) - 19.0 percent, Asia-Pac - 29.0 percent, RoW - 9.0 percent

Key competitors operating in the competent cells market contain Thermo Fisher Scientific (NYSE:TMO), Merck KGaA (MKGA), GenScript Biotech Corporation, Agilent Technologies (NYSE:A), Takara Bio, Incorporated, Promega Corporation, BioRad (NYSE:BIO), Qiagen NV (NASDAQ:QGEN), and New England Biolabs, Incorporated.

Scope of the Report:

The report analyses the competent cells market by category, application, end-user, and area. Apart from comprehensive geographic and product review and sizing of market, the industry report also offers the competitive landscape that includes the increase strategies approved by sector actors over the last three years. Additionally, the report profiles firms with product types, advancements, and strategies approved by top players to maintain and rise their companies in the industry. The above-mentioned segment research data, market value, and forecast of the future trends will facilitate top market players and new sector entrants to make the necessary decisions to be successful in the market.

Benefits of Buying this Report:

This business report will allow both established firms as well as new entrants/smaller companies gauge the pulse of the sector, which in turn will facilitate these companies collect greater segment market share. Companies obtaining the study can use any one or a combination of the five strategies mentioned below to strengthen their market shares.

The analysis offers business insights on the following strategies:

• Market Uptake: Exhaustive data on the product portfolios of the top actors in the competent cells market. The market research examines the competent cells market by category, application, and end user

• opposing assessment: In-depth assessment of the market strategies, geographic and industry segments, and product review of the main players in the competent cells market

• Market Development: Highlighted information about emerging sectors. This industry report examines the sector for different competent cell products across geographies

• industry diversification: Complete information about recent products, untapped areas, recent evolutions, and market investments in the competent cells market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Synthetic Biology Market by Tool, Technology, Application, Industrial - Global Forecast to 2022

Synthetic Biology Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • December 2017
  • by MarketsandMarkets

The global synthetic biology market is projected to grow at a CAGR of 19.9%. in the next five yearsThe synthetic biology market is expected to reach USD 8.84 billion by 2022 from an estimated USD 3.57 ...

Recombinant DNA Technology Market Analysis By Product, By Component, By Application, By End-use And Segment Forecasts, 2014 - 2025

Recombinant DNA Technology Market Analysis By Product, By Component, By Application, By End-use And Segment Forecasts, 2014 - 2025

  • $ 5950
  • Industry report
  • August 2017
  • by Grand View Research

Recombinant DNA Technology Market Analysis By Product (Therapeutic Agent, Vaccine, Biotech Crops, Specialty Chemicals), By Component, By Application, By End-use, And Segment Forecasts, 2014 - 2025The global ...

Synthetic Biology – A Global Market Overview

Synthetic Biology – A Global Market Overview

  • $ 4950
  • Industry report
  • April 2018
  • by Industry Experts

Report SynopsisThe major factors propelling growth of Synthetic Biology market include declining prices of DNA sequencing and synthesis, materialization of innovative technologies, increased funding from ...


Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on